-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Solid Biosciences, Raises Price Target to $20

Benzinga·08/21/2026 17:30:05
Listen to the news
Truist Securities analyst Danielle Brill maintains Solid Biosciences (NASDAQ:SLDB) with a Buy and raises the price target from $16 to $20.